Related Experiment Video
Updated: Dec 27, 2025

07:44
TMT Sample Preparation for Proteomics Facility Submission and Subsequent Data Analysis
Published on: June 8, 2020
13.2K
Proteomics of Select Neglected Tropical Diseases
Anthony J Saviola1, Fernanda Negrão2, John R Yates1
1Department of Molecular Medicine and Neurobiology, The Scripps Research Institute, La Jolla, California 92037, USA;
Annual Review of Analytical Chemistry (Palo Alto, Calif.)
|February 29, 2020
Summary
Mass spectrometry-based proteomics offers insights into neglected tropical diseases (NTDs). This approach aids in understanding disease mechanisms, identifying drug targets, and discovering diagnostic biomarkers for conditions like Buruli ulcer and dengue.
Area of Science:
- Proteomics and Mass Spectrometry
- Molecular basis of infectious and tropical diseases
Background:
- Proteins are crucial in disease processes, often altered by external stimuli.
- Proteomics, the large-scale study of proteins, is vital for understanding disease at a molecular level.
- Neglected tropical diseases (NTDs) are disabling conditions predominantly affecting impoverished tropical and subtropical populations.
Purpose of the Study:
- To review the application of mass spectrometry-based proteomics in studying the pathogenesis, etiology, and pathology of selected NTDs.
- To highlight how proteomics aids in understanding disease mechanisms and identifying therapeutic targets.
- To showcase the role of proteomics in discovering biomarkers for early diagnosis of NTDs.
Main Methods:
- Review of existing literature on mass spectrometry-based proteomic studies.
- Focus on specific NTDs: Buruli ulcer, dengue, leishmaniasis, and snakebite envenoming.
- Analysis of proteomic data to elucidate pathogenic mechanisms and identify potential biomarkers and drug targets.
Main Results:
- Proteomic studies provide significant information on the pathogenic mechanisms of the reviewed NTDs.
- Identification of molecular targets crucial for drug discovery and development against these diseases.
- Discovery of promising protein biomarkers that can aid in the early diagnosis of NTDs.
Conclusions:
- Mass spectrometry-based proteomics is an invaluable tool for advancing the understanding and management of NTDs.
- Proteomic insights facilitate the development of novel diagnostics and therapeutics for neglected tropical diseases.
- Continued proteomic research is essential for combating the burden of NTDs globally.

